Giovanni Paolino

45PUBLICATIONS
101CO-AUTHORS
AllergyAutoimmunityMedical biochemistry - lipidsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jun 30, 2026
Distinctive Reactivity to the C-terminal Epitope of BP180 Characterizes Immune Checkpoint Inhibitor-associated Bullous Pemphigoid, and an ELISA Based on the BP180 Ectodomain Enables Prompt Diagnosis in a Subset of Patients.

|May 19, 2026
Targeting type I interferon in lupus panniculitis: a case-based systematic literature review.

|Apr 17, 2026
The relevance of membrane lipid composition in exosome-based precision dermatology.

|Mar 23, 2026
Lebrikizumab After Multiple Prior Advanced Therapies in Moderate-To-Severe Atopic Dermatitis: A Real-World Case Series.

Giovanni Paolino, Matteo Riccardo Di Nicola, Luciano Ibba

|Nov 26, 2025
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

A Carugno, G Nazzaro, L Argnani

|Oct 29, 2025
Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option.

Giovanni Paolino, Raffaele Dante Caposiena Caro, Mario Valenti

Pageof 8

Frequent Collaborators

10 joint publications

Matteo Riccardo Di Nicola

8 joint publications

Carmen Cantisani

6 joint publications

Riccardo Pampena

4 joint publications

Angelo Valerio Marzano